Cindy Chmielewski @MyelomaTeacher
@myelomateacher.bsky.social
Wife, mother, “retired” educator and animal lover. #Myeloma patient Dx 2008 - Myeloma research advocate #mmsm
Its always nice to hear from the basic researchers. Their successes in the lab eventually transfer to patient care. Thanks! youtu.be/VHE5-RQJnf8?... #MMsm #ASH24 #HealthTree #myeloma
Beating T-Cell Exhaustion: The Future of Myeloma Care | Marta Chesi & Erin Meermeier | #ASH24
YouTube video by HealthTree Foundation for Multiple Myeloma
youtu.be
Today’s ASH highlight video is on Cevostamab-a fixed duration bispecific antibody that targets FCRH5 youtu.be/kHNBPB1S7QY?... #MMsm #ASH24 #HealthTree #myeloma
Cevostamab, a FcRH5 bispecific antibody, for RRMM | Joshua Richter, MD | #ASH2024
YouTube video by HealthTree Foundation for Multiple Myeloma
youtu.be
Daratumumab vs Lenalidomide As Myeloma Maintenance Therapy | Sridevi Rajeeve, MD | #ASH24 youtu.be/oZfpQWdgiSc?...
Daratumumab vs Lenalidomide As Myeloma Maintenance Therapy | Sridevi Rajeeve, MD | #ASH24
YouTube video by HealthTree Foundation for Multiple Myeloma
youtu.be
Another Myeloma maintenance study- Auriga Study Subgroup Update - youtu.be/xKaOtop1fik?... #MMsm #ASH24 #HealthTree #myeloma
Daratumumab + Lenalidomide Vs Lenalidomide Alone As Maintenance Therapy | Laahn Foster, MD | #ASH24
YouTube video by HealthTree Foundation for Multiple Myeloma
youtu.be
Happy to see patients as influencers at major medical meetings. It is so important to include all perspectives in the conversations. #MMsm #ASH24 #HealthTree #myeloma
To treat or not to treat (HR-SMM) - Listen to @thanosdimop talk about the results of the Aquila trial #MMsm #ASH24 #HealthTree #myeloma youtu.be/C7f-cTLBBfo
Daratumumab vs Observation in High-Risk SMM (Aquila Study) | Meletios Dimopoulos, MD | #ASH24
YouTube video by HealthTree Foundation for Multiple Myeloma
youtu.be
Reaching MRD negativity is the goal of #myeloma treatment. The CoMMander trial used Iberdomide to achieve this in Post-ASCT patients who had residual disease after 100 days. @healthtreeorg.bsky.social #MMSM #ASH24 m.youtube.com/watch?v=MiWM...
Iberdomide Combos Post-ASCT in Myeloma: Eliminating Residual Disease (COMMANDER) |Dr. Costa | #ASH24
YouTube video by HealthTree Foundation for Multiple Myeloma
m.youtube.com
New-to-blue but feared by myeloma and well-known to the myeloma world: @drmhb.bsky.social moderating #ASH24 myeloma treatment session
Tri-specific Antibody #SAR442257 in RRMM and Non- Hodgkin Lymphoma #MMsm #ASH24 #HealthTree #myeloma youtu.be/7NzP-E9WnRo
Tri-specific Antibody SAR442257 in RRMM and Non- Hodgkin Lymphoma | Fredrik Schjesvold | #ASH24
YouTube video by HealthTree Foundation for Multiple Myeloma
youtu.be
There is a new CAR on the block and it’s performing exceptionally well. This is one of the many videos that is posted on the @HealthTree for Multiple Myeloma YouTube channel where our ASH coverage will be featured . #MMsm #ASH24 #HealthTree #myeloma youtu.be/sx89o8X7vvU
Phase 1 Study of Antio-cel an Anti-BCMA CAR-T for RRMM | Michael Bishop | #ASH24
YouTube video by HealthTree Foundation for Multiple Myeloma
youtu.be
Thanks for including a patient advocate on this important research project! #MMsm #ASH24 #HealthTree #myeloma
Al Garfall@algarfall.bsky.social · 2y agoIt was wonderful to get together in-person with our multi-site team working on the LimiTec trial of limited-duration teclistamab therapy for rel/ref #myeloma at #ASH24! Thanks to Leukemia & Lymphoma Society for supporting our trial! clinicaltrials.gov/study/NCT059... @myelomateacher.bsky.social
Myeloma / Plasma Cell Dyscrasia ~ #ASH24Top10 (or so) #mmsm #mmMRD #ASH24 - @mtmdphd - Update: 12/4/24 - cc @grpetersen1 - @bdermanmd @bhemato @DrOlaLandgren @End_myeloma @HadidiSamer @jmikhaelmd @ManniMD1 @MeeraMohanMD @MyelomaTeacher @RahulBanerjeeMD @rajshekharucms @szusmani @Taxkourel @VincentRK
Myeloma / Plasma Cell Dyscrasia ~ #ASH24Top10 (or so) #mmsm #mmMRD #ASH24 - @mtmdphd *DRAFT* Table Update: Nov 26, 2024 v2 - cc @grpetersen1 - @bdermanmd @HadidiSamer @jmikhaelmd @MyelomaTeacher @RahulBanerjeeMD @rajshekharucms @szusmani et al.
Myeloma / Plasma Cell Dyscrasia ~ #ASH24Top10 (or so) #mmsm #mmMRD #ASH24 - @mtmdphd *DRAFT* Table Update: Nov 20, 2024 - cc @grpetersen1 - @HadidiSamer @jmikhaelmd @MyelomaTeacher @RahulBanerjeeMD @szusmani et al.
